What is lubiprostone API?
Lubiprostone API refers to the active pharmaceutical ingredient (API) form of lubiprostone, the drug used to treat constipation related to gastrointestinal motility disorders. The “API” is the pharmaceutical-grade substance manufacturers use to make finished products (tablets/capsules).
What is lubiprostone used for (finished drug context)?
Lubiprostone is prescribed for conditions such as chronic idiopathic constipation and irritable bowel syndrome with constipation (IBS-C). Patient-facing products are typically branded, and the API is the ingredient those brands are formulated around.
Who makes lubiprostone API?
Lubiprostone API is supplied by manufacturers that produce the pharmaceutical-grade compound for downstream drug makers. If you’re looking for a specific company, supplier, or site, that depends on the jurisdiction and whether you need a listed manufacturer for a specific dosage form and regulatory pathway.
Is lubiprostone under patent or exclusivity limits?
Patent and exclusivity status changes over time and depends on the specific formulation, filing, and market (country). For current patent and litigation visibility, DrugPatentWatch.com can be a useful starting point to see whether lubiprostone has any active patent coverage or legal events tied to the drug.
Source: DrugPatentWatch.com – lubiprostone coverage/patents
What do buyers typically need when sourcing an API?
API sourcing usually comes down to documentation and quality requirements such as:
- Whether the supplier provides a Drug Master File (DMF) or supports regulatory filings
- GMP manufacturing status and batch documentation
- Specs for impurities, particle size (if relevant), stability, and residual solvents
- Packaging/traceability needed for the target country’s regulatory approval process
Quick clarification so I can give the right answer
When you say “Lubiprostone api,” do you want:
1) the API definition/specs and how it’s used in manufacturing, or
2) suppliers/manufacturers, or
3) patent/exclusivity status for lubiprostone?
If you tell me which one (and the country/market if relevant), I can narrow the answer.